SAN DIEGO, Oct. 15 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. today announced that the Company’s Principal Executive Officer, Brian M. Culley, will present at the BIOCOM Investor Conference on Monday, October 26, 2009, at 10:00 a.m. Pacific time, at the Hyatt Regency in La Jolla, California.
Interested parties can access a live audio webcast and slide presentation on the ADVENTRX Pharmaceuticals Web site at www.adventrx.com. An archived presentation will be available on the Web site for 30 days.
About ADVENTRX Pharmaceuticals
ADVENTRX Pharmaceuticals is a specialty pharmaceutical company whose product candidates are designed to improve the safety of existing cancer treatments. More information can be found on the Company’s web site at www.adventrx.com.
SOURCE ADVENTRX Pharmaceuticals, Inc.
CONTACT: Brian Culley, Principal Executive Officer of ADVENTRX
Pharmaceuticals, +1-858-552-0866; or Investors, Don Markley of
Lippert/Heilshorn & Associates, Inc., +1-310-691-7100, dmarkley@lhai.com,
for ADVENTRX Pharmaceuticals
Web site: http://www.adventrx.com/
